Latest Updates

US FDA approves Mylan and Biocon’s Fulphila

Read more

Lupin gets US FDA nod to market fungal infection cream

Read more

FDA chief outlines new ways to speed cancer drug approvals

Read more

TMH team presents Biocon’s cancer study results at ASCO Annual Meeting 2018

Read more

Lupin launches generic drug in the US

Read more

Alembic Pharma plans Rs 720-crore CAPEX for FY19

Read more

Bayer to close $62.5 bn Monsanto takeover deal

Read more

Serum Institute of India in MoU with Intravacc to develop bioneedles

Read more

Novartis wins key European panel’s thumbs-up for migraine drug

Read more

Torrent Pharma Q4 net up 11% at ₹ 228 crore

Read more